Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Semaglutide — the active ingredient in Ozempic®, Wegovy®, and Rybelsus® — can reduce your appetite and curb food cravings to promote weight loss.

In a 36-week study, semaglutide was found to aid in weight loss for people with schizophrenia without worsening psychotic symptoms. Participants lost nearly 14% of body weight, and there was an ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared with placebo.

Exhibit A: Adelphi’s 10-goal third quarter outburst. Molloy’s Brian Green (three goals, one assist) scored with a man-up with 12:34 left in the third quarter to cut Adelphi’s lead to 8-3.

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

Semaglutide, widely used for diabetes and weight loss, shows strong potential in reversing fatty liver disease, offering hope for millions affected by MASH globally.

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...

Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.